D(4) DOPAMINE RECEPTOR

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Jun 26 16:52:01 UTC 2021` Edited by `admin` on `Sat Jun 26 16:52:01 UTC 2021`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	RI471QC62V
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

D(4) DOPAMINE RECEPTOR

Common Name

English

DRD4

Common Name

English

D(2C) DOPAMINE RECEPTOR

Common Name

English

Code System Code Type Description

FDA UNII

RI471QC62V

Created by admin on Sat Jun 26 16:52:02 UTC 2021 , Edited by admin on Sat Jun 26 16:52:02 UTC 2021

PRIMARY

PHAROS

P21917

Created by admin on Sat Jun 26 16:52:02 UTC 2021 , Edited by admin on Sat Jun 26 16:52:02 UTC 2021

PRIMARY

UNIPROT

P21917

Created by admin on Sat Jun 26 16:52:02 UTC 2021 , Edited by admin on Sat Jun 26 16:52:02 UTC 2021

PRIMARY

From	To
1_108	1_185

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_3

Related Record Type Details


					9T7B8CV47A

AGONIST -> TARGET


					N21FAR7B4S

AGONIST -> TARGET

Comments:

Emax 45% Emax 82% Transfected CHO cells

Qualification:

EC50

Amount:


					G7FMS28PYD

PD-172760

INHIBITOR -> TARGET


					8X35VUU4YY

AGONIST -> TARGET


					838F01T721

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

Ki

Amount:


					L6UH7ZF8HC

3-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYRIDO(1,2-A)PYRIMIDIN-4-ONE

ACTIVATOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

Ki

Amount:


					83619PEU5T

AGONIST -> TARGET


					X8L60BA01I

PARTIAL AGONIST->TARGET


					87T4T8BO2E

AGONIST -> TARGET


					2A5XS99U8Q

PD-168077

AGONIST -> TARGET

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT	CHEMICAL